Skip to main content
Publications
Dong OM, Roberts MC, Wu RR, Voils CI, Sperber N, Gavin KL, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Chapman JG, Voora D. Evaluation of the veterans affairs pharmacogenomic testing for veterans (PHASER) clinical program at initial test sites. Pharmacogenomics. 2021 Nov 1;22(17):1121-33. doi: 10.2217/pgs-2021-0089
Dong OM, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Meyer LJ, Icardi M, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Jacobitz R, Rozelle S, Chapman JG, Voora D. Institutional profile: veterans affairs pharmacogenomic testing for veterans (PHASER) program. Pharmacogenomics. 2021 Jan 6;22(3):2020-0173. doi: 10.2217/pgs-2020-0173
Robertson G, Fleming A, Williams MC, Trucco E, Quinn N, Hogg RE, McKay GJ, Pellegrini E, Newby DE, van Beek EJ, Peto T, Dhillon B, van Hemert J, Macgillivray T. Screening for hypertension using retinal vascular calibre in ultra-widefield fundus imaging. Poster presented at the American Heart Association's Joint Hypertension 2018 Scientific Sessions; September 6, 2018. Chicago, IL. [abstract] Hypertension. 2018 Dec 6; 72:AP400. doi: 10.1161/hyp.72.suppl_1.P400